logo







Home>Companies>Nuvation-bio-nys-nuvb


Nuvation bio (nys: nuvb)

Nuvation bio (nys: nuvb)



Nuvation Bio (NYS: NUVB) is a biopharmaceutical company focused on addressing unmet needs in oncology through the development of innovative therapeutic candidates, including its clinical-stage product NUV-868, a selective oral small molecule BET inhibitor targeting key proteins involved in tumor growth.
Sign up today to get real-time market insights on Nuvation bio (nys: nuvb) and hundreds of other pre-IPO companies



Nuvation bio (nys: nuvb) Overview

New York, NY, United States
2018
Biotech
https://www.nuvationbio.com



Nuvation bio (nys: nuvb) Live Market Data

$00000000
$00000000




Nuvation bio (nys: nuvb) Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
Reverse Merger2/10/2021
Series A10/15/2020




Nuvation bio (nys: nuvb) Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
Altitude Life Science VenturesSeries ASeries A (2020-10-15)
EDBISeries ASeries A (2020-10-15)
Fidelity InvestmentsSeries ASeries A (2020-10-15)




Nuvation bio (nys: nuvb) 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Nuvation bio (nys: nuvb) data




Nuvation bio (nys: nuvb) Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Nuvation bio (nys: nuvb) data




Latest Nuvation bio (nys: nuvb) News







Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.